Solution Title: CONGENITAL HEART DISEASE SCREENING IN THE NEWBORN

Similar documents
11/27/2012. Objectives. What is Critical Congenital Heart Disease?

CCHD Screening with Pulse Oximetry: A Success Story!

Screening for Critical Congenital Heart Disease in the Apparently Healthy Newborn

Implementation of Newborn Screening for Critical Congenital Heart Disease (CCHD) in New York State

5/22/2013. Alan Zuckerman 1, Swapna Abhyankar 1, Tiffany Colarusso 2, Richard Olney 2, Kristin Burns 3, Marci Sontag 4

Pulse Oximetry Screening in Newborns to Enhance the Detection Of Critical Congenital Heart Disease. Frequently Asked Questions

Talking with Parents about a Positive Critical Congenital Heart Disease (CCHD) Screen or Test. Emily Drake, PhD RN May 20, 2014.

Objectives. Prenatal Diagnosis of Critical Congenital Heart Disease. The Law. Disclosure. Dylan s Story

Disclosure. This presentation is the intellectual property of the author. Contact them for permission to reprint and/or distribute.

Global Postoperative Mortality in Critical Congenital Heart Disease: A Systematic Review

The Fetal Cardiology Program

Screening for Critical Congenital Heart Disease

(f) "Birthing center" means any facility that is licensed by the Georgia Department of Community Health as a birthing center;

Critical congenital heart disease screening by pulse oximetry in a neonatal intensive care unit

How to Recognize a Suspected Cardiac Defect in the Neonate

Screening Compliance for Critical Congenital Heart Disease in Texas Newborns

Congenital Heart Disease. CCCHD In WI. Critical Congenital Heart Disease. Why Screen? 4/20/2018. Early Detection = Better Outcomes

Date January 20, Contact Information

Critical Congenital Heart Defects Screening

BORN Project Newborn Pulse Oximetry Screening Mianyang, Sichuan

Disclosure. Pediatrics Grand Rounds 18 October University of Texas Health Science Center at San Antonio, Texas. Objectives

Pulse oximetry screening in newborns to enhance detection of critical congenital heart disease

Factors Associated With Late Detection of Critical Congenital Heart Disease in Newborns

The Fetal Care Center at NewYork-Presbyterian/ Weill Cornell Medicine

Pulse oximetry screening in newborns to enhance detection of critical congenital heart disease

Can echocardiographic screening in the early days of life detect critical congenital heart disease among apparently healthy newborns?

Positive predictive value of pulse oximetry in the screening of critical congenital heart defects in term neonates

Standard of Newborn Care in the Age of Birth Plans. Stephanie Deal, MD Tiffany McKee-Garrett, MD

Age at Referral and Mortality From Critical Congenital Heart Disease. abstract

CYANOTIC CONGENITAL HEART DISEASES. PRESENTER: DR. Myra M. Koech Pediatric cardiologist MTRH/MU

Am I Blue? Newborn Pulse Oximetry Screening for Critical Congenital Heart Disease The State of the State

IMAGES. in PAEDIATRIC CARDIOLOGY

Routine Screening for Critical Congenital Heart Disease in Healthy Newborns

Testing the Sensitivity and Specificity of right hand and foot pulse oximetry for the detection of congenital heart defects in Saudi Arabia.

Cardiology Competency Based Goals and Objectives

MIDWIVES & CCHD PULSE OXIMETRY SCREENING

Cardiovascular Pathophysiology: Right to Left Shunts aka Cyanotic Lesions

Cardiovascular Pathophysiology: Right to Left Shunts aka Cyanotic Lesions Ismee A. Williams, MD, MS Pediatric Cardiology

Potential Data Sources

Spectrum and age of presentation of significant congenital heart disease in KwaZulu Natal, South Africa

ARTICLE. Missed Diagnosis of Critical Congenital Heart Disease. Ruey-Kang R. Chang, MD, MPH; Michelle Gurvitz, MD; Sandra Rodriguez, MS

MNSCREEN TRAINING MANUAL Hospital Births Newborn Screening Program October 2015

Disclosures. Practical Aspects of Pediatric Cardiology for the General Practitioner. Objectives. Outlines. CCHD Neonatal Screening

Regional Prenatal Congenital Heart Disease Detection and Practices Lori Erickson MSN, RN, CPNP-PC Ward Family Heart Center

Lessons Learned From Newborn Screening for Critical Congenital Heart Defects

RESULTS REPORTING MANUAL. Hospital Births Newborn Screening Program June 2016

Newborn Screening: Train the Trainer PPT Questions

Regional Prenatal Congenital Heart Disease Detection and Practices Jenny Ecord, APRN Ward Family Heart Center Wichita

Stabilization and Transportation guidelines for Neonates and infants with Heart disease:

Statement of Organization, Functions, and Delegations of Authority. Part C (Centers for Disease Control and Prevention) of the Statement of

PRACTICE GUIDELINES WOMEN S HEALTH PROGRAM

MINNESOTA EARLY HEARING DETECTION AND INTERVENTION (EHDI) PROGRAM. EHDI Goals, Indicators and Benchmarks

Congenital Heart Defects

EHDI National EHDI Meeting

: Provide cardiovascular preventive counseling to parents and patients with specific cardiac diseases about:

Trust Guideline on Routine Oxygen Saturation Measurement on the New-born (Pulse Oximetry)

NEONATAL CLINICAL PRACTICE GUIDELINE

SEX, BIRTH ORDER, AND MATERNAL AGE CHARACTERISTICS OF INFANTS WITH CONGENITAL HEART DEFECTS

Before we are Born: Fetal Diagnosis of Congenital Heart Disease

NEWBORN SCREENING PRENATAL CURRICULUM

Appendix C NEWBORN HEARING SCREENING PROJECT

Pediatrics. Blue Baby Syndrome (Cyanotic Newborn) and Hyperoxia Test. Definition. See online here

Incidence of congenital heart disease

3/14/2011 MANAGEMENT OF NEWBORNS CARDIAC INTENSIVE CARE CONFERENCE FOR HEALTH PROFESSIONALS IRVINE, CA. MARCH 7, 2011 WITH HEART DEFECTS

The Blue Baby. Network Stabilisation of the Term Infant Study Day 15 th March 2017 Joanna Behrsin

AMERICAN ACADEMY OF PEDIATRICS

Transient malformations like PDA and PDA of prematurity were not considered. We have divided cardiac malformations in 2 groups:

abstract SPECIAL ARTICLE

Congenital Heart Disease

Kansas Successful Strategies in Reducing Loss to Follow-Up/Loss to Documentation

A SURGEONS' GUIDE TO CARDIAC DIAGNOSIS

Absent Pulmonary Valve Syndrome

E ven though a thorough physical examination of every

New Waves of Newborn Screening: What's Next on the Horizon!

Congenital CMV (ccmv) Initiatives Across the United States: A Panel Discussion

Management of a child with cyanosis

RESEARCH ABSTRACT INTRODUCTION

Congenital Heart Disease in the United States of America: Guidelines

Global Screening of Hearing in Newborns. Update from Portugal

9/8/2009 < 1 1,2 3,4 5,6 7,8 9,10 11,12 13,14 15,16 17,18 > 18. Tetralogy of Fallot. Complex Congenital Heart Disease.

CongHeartDis.doc. Андрій Миколайович Лобода

PAEDIATRIC EMQs. Andrew A Mallick Paediatrics.info.

Preterm Birth Initiative Community Advisory Board Application

5 HEALTH PRIORITIES, 10 OUTCOME MEASURES

Spinal Muscular Atrophy Newborn Screening

JFK-HCP Webinar - Partnering to Support Children with Hearing Loss - 2/27/14 1

Methods PEDIATRIC CARDIOLOGY

Total Anomalous Pulmonary Venous Connections: Anatomy and Diagnostic Imaging

Guam Early Hearing Detection and Intervention

The Aboriginal Maternal and Infant Health Service: a decade of achievement in the health of women and babies in NSW

The background of the Cardiac Sonographer Network News masthead is a diagnostic image:

Cyanotic spells in Tetralogy of Fallot

Delivery Room Resuscitation of Newborns with Congenital Anomalies

Reducing Maternal Mortality & Morbidity Surveillance & Action

Actionable Patient Safety Solution (APSS) for #7B: FAILURE TO DETECT CRITICAL CONGENITAL HEART DISEASE (CCHD) IN NEWBORNS

Hypothermia at Birth and its Associated Complications in Newborns: a Follow up Study

A PARENT S POCKET GUIDE

Medical Specialists. SPECIALTY (type in contact name and phone number)

Transcription:

Institutional Affiliation: ANNE ARUNDEL MEDICAL CENTER Solution Title: CONGENITAL HEART DISEASE SCREENING IN THE NEWBORN Program/Project Description Congenital heart defects in general, and newborn screening programs for critical congenital heart disease (CCHD) specifically, have become new public health priorities in the United States. In the United States, about 4,800 (or 11.6 per 10,000) babies born every year have one of seven critical congenital heart defects: Hypoplastic left heart syndrome Pulmonary atresia Tetralogy of Fallot Total anomalous pulmonary venous return Transposition of the great arteries Tricuspid atresia Truncus arteriosus These seven types of CCHD usually present in newborns with hypoxemia that might be missed clinically but identified by pulse oximetry. It is estimated that at least 280 infants with an unrecognized CCHD are discharged each year from newborn nurseries in the United States. These babies are at risk of having serious complications within the first few days or weeks of life and often require emergency care. Newborn screening for CCHD, added in September 2011 to the Recommended Uniform Screening Panel in the United States, is a new public health priority and has particular relevance for state birth defects surveillance programs. Goals: 1. Conduct screening on all newborns at Anne Arundel Medical Center to identify those newborns with structural heart defects that are usually associated with hypoxia in the newborn period and could result in morbidity or mortality early in life. 2. Goal: At least 80% of babies to be reported as screened in the first quarter of implementation with an increase each quarter over the first year. Process: The quality improvement project included the following steps: Identified and engaged key stakeholders.

Formation of a multidisciplinary team including physicians, nurses, administration, and ancillary staff to develop standard newborn screening tools for CCHD. Multidisciplinary meeting to determine implementation plan including hospital screening protocol and equipment, follow up for newborns with failed screens, screening in NICU, documentation and reporting. Cindy Mueller developed the Mueller CCHD Screening Table as a tool to determine if a newborn has passed the screening, needs to be rescreened according to the protocol or has failed and needs further testing. This screening table standardized the process used by staff to determine next steps with ease. Engaged clinical providers including Pediatricians, Cardiologists, Neonatologists, Obstetricians and Nurse Midwives participated in a quality improvement project for standard work in identification of CCHD. Solution: Mandatory staff education provided screening and follow-up of positive screens done appropriately. A variety of training methods were used including Webinar attendance, selflearning packets with scenarios, presentation by a Cardiologist at Pediatric Service meeting and formal lectures. Completion of a knowledge assessment quiz was required for all the nursing staff. Trainings are provided accordingly for newly hired staff to ensure that 100% of staff is educated. Newborns are now screened between 24-48 hours of age. Premature infants in the NICU are screened when the carseat test is performed. All newborns that fail the CCHD are transferred to the NICU for evaluation. Measureable Outcomes: We have successfully implemented Critical Congenital Heart Disease Screening on newborns at Anne Arundel Medical Center. We have not identified any newborns that were undiagnosed prenatally with any of the seven Critical Congenital Heart defects. There were two infants with underlying respiratory illness identified as a result of CCHD screening. Inclusion of pulse oximetry screening in newborn care did not result in a strain on pediatricians, neonatologists or ECHO technicians due to additional evaluations of outcomes failed screens. Implementation of CCHD screening began on September 1, 2012. From September 2012 - November 2012, of 1381 eligible newborns, 1350 newborns were screened. Outcomes data reported by the State: 9/2012 88% screened

10/1012 96% screened 11/2012 98% screened Over first 3 months, 78% of infants were reported as being screened; during the fourth month, November 87%, infants were reported as being screened for CCHD. According to recent data Anne Arundel Medical Center has met goal of 100% infants are being screened before discharge. September 2012 Total Newborns Screened or Medical Override Percent of Newborns Screened Percent of Newborns who Passed Screening Anne Arundel Medical Center 444 88% 99.8% State of Maryland 4353 77% 99.8% Sustainability: Sustainability is maintained by using the standard screening tools and guidelines when assessing the newborns before discharge. The State of Maryland is using standard tools and guidelines as well as sharing with other States the current tools. This will provide reliable data for successful outcomes in screening for CCHD. Role of Collaboration and Leadership Cindy Mueller was sponsored by Sherry Perkins PhD, RN, Chief Nursing Officer/Chief Operating Officer to participate at the State level for CCHD education and planning. Cindy was supported by NICU Clinical Director and selected as a team member for one of the 20 multidisciplinary teams forming a collaborative around CCHD screening in newborns. The support of many leaders throughout the State and area hospitals provided the time to develop partnerships and create a standard tool for successful CCHD screening tool with education and protocols to all staff, families and communities. The key elements of the program allowed on-site learning through participation in both the annual all-cohort conferences and regional meetings. In addition, there were distance learning through interactive-webinars and e-learning events, coaching and technical assistance provided by expert practitioners and specialists that provided the foundation to develop the new screening tools. Most of the work was led by National Leadership Academy for the Public s Health (NLAPH).

Innovation: The multi-collaborative teamwork and development of the CCHD screening tool exemplify patient safety measures to assure newborns assessments for CCHD before discharge are completed and leave little to no error in missing components. The design of the Mueller screening table provides a pictorial view to simplify the reading of the CCHD results to assure a safety net for all practitioners engaged in reading the results. These opportunities in sharing knowledge led Cindy to develop the Mueller table has provided a standard measure for safe assessment and results. Related Tools and Resources Mueller CCHD Screening Table Green= Negative Screen (PASS) Red=Rescreen in 1 hour Red for 3 consecutive screens= (FAIL) *Red*= Automatic (FAIL) RIGHT HAND FOOT <90 100 100 99 98 97 96 95 94 93 92 91 90 * 99 100 99 98 97 96 95 94 93 92 91 90 * 98 100 99 98 97 96 95 94 93 92 91 90 * 97 100 99 98 97 96 95 94 93 92 91 90 * 96 100 99 98 97 96 95 94 93 92 91 90 * 95 100 99 98 97 96 95 94 93 92 91 90 * 94 100 99 98 97 96 95 94 93 92 91 90 * 93 100 99 98 97 96 95 94 93 92 91 90 * 92 100 99 98 97 96 95 94 93 92 91 90 * 91 100 99 98 97 96 95 94 93 92 91 90 * 90 100 99 98 97 96 95 94 93 92 91 90 * <90 * * * * * * * * * * * <90

Critical Congenital Heart Disease (CCHD) Screening Algorithm - AAMC Newborn is screened between 24 and 48 hours of age. If newborn is being discharged before 24 hours of age, screening is done shortly before discharge. Screen < 90% in right hand or foot = 90% - 94% in right hand and foot or >3% difference between right hand and foot Repeat screen in 1 hour >95% in right hand or foot and <3% difference between right hand and foot = Negative Screen (Passed Test) < 90% in right hand or foot = 90% - 94% in right hand and foot or >3% difference between right hand and foot >95% in right hand or foot and <3% difference between right hand and foot = Negative Screen (Passed Test) Repeat screen in 1 hour < 90% in right hand or foot = 90% - 94% in right hand and foot or >3% difference between right hand and foot >95% in right hand or foot and <3% difference between right hand and foot = Negative Screen (Passed Test) Call NICU NNP; Transfer baby s care to Neonatology Service Negative Screen (Passed Test) Continue normal newborn care Contact Person: Title: Cindy Mueller BSN, RN Email: cmueller@aahs.org Phone: 410-991-5037

References Kemper AR, Mahle WT, Martin GR, Cooley WC, Kumar P, Morrow RW, et al. Strategies for implementing screening for critical congenital heart disease: recommendations of the United States Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children. Pediatrics. 2011;128 (5:e1259 e1267) Mahle WT, Newburger JW, Matherne GP, Smith FC, Hoke TR, Koppel R, et al. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Pediatrics. 2009;124:823 836